AMYLYX PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.83 USD | -1.08% |
|
+12.96% | -87.57% |
| 24/06 | Amylyx Pharmaceuticals, Inc.(NasdaqGS:AMLX) dropped from S&P Pharmaceuticals Select Industry Index | CI |
| 21/06 | Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar | RE |
Quotes 5-day view
Delayed Quote Nasdaq| 21/06/2024 | 24/06/2024 | 25/06/2024 | 26/06/2024 | |
|---|---|---|---|---|
| Last | 1.78 $ | 1.83 $ | 1.85 $ | 1.83 $ |
| Volume | 4 040 372 | 2 832 467 | 2 149 379 | 1 828 875 |
| Change | +7.88% | +2.81% | +1.09% | -1.08% |
| Opening | 1.64 | 1.80 | 1.85 | 1.85 |
| High | 1.78 | 1.91 | 1.89 | 1.90 |
| Low | 1.64 | 1.79 | 1.81 | 1.81 |
Performance
| 1 day | -1.08% | ||
| 1 week | +12.96% | ||
| Current month | +6.40% | ||
| 1 month | +5.78% | ||
| 3 months | -33.21% | ||
| 6 months | -87.15% | ||
| Current year | -87.57% | ||
| 1 year | -91.84% |
Volumes
marketsDaily volume
1 828 875
Estimated daily volume
1 828 875
Avg. Volume 20 sessions
1 479 476
Daily volume ratio
1.24
Avg. Volume 20 sessions USD
2 707 441.08
Record volume 1
61 466 830
Record volume 2
21 153 080
Record volume 3
17 505 626
Capital turnover ratio
0.02
Float rotation
0.03
Basic data
Capitalization (USD)
124 450 520
Net sales (USD)
380 786 000
Number of employees
384
Sales / Employee (USD)
991 630
Free-Float
85.34 %
Free-Float capitalization (USD)
106 200 261
Average Daily Capital Traded
2.18%
Highs and lows
1 week
1.64
1.91
1 month
1.581.91
Current year
1.5819.95
1 year
1.5825.48
3 years
1.5841.93
5 years
1.5841.93
10 years
1.5841.93
Indicators
Moving average 5 days
1.79
Moving average 20 days
1.72
Moving average 50 days
1.82
Moving average 100 days
5.71
Price spread / (MMA5)
-2.30%
Price spread / (MMA20)
-6.07%
Price spread / (MMA50)
-0.53%
Price spread / (MMA100)
+212.21%
STIM
RSI 9 days
66.94
RSI 14 days
51.54
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.08% | +12.96% | -87.57% | -91.84% | 124M | ||
| +0.09% | +1.52% | +2.97% | +5.77% | 94.74B | ||
| -1.22% | -3.44% | -4.08% | -4.08% | 37.28B | ||
| +0.57% | +0.36% | -13.26% | -20.29% | 32.68B | ||
| +0.40% | +0.44% | +74.21% | +72.89% | 27.72B | ||
| +0.33% | +1.31% | -11.58% | -7.63% | 16.19B | ||
| -2.14% | +0.50% | -1.66% | -1.89% | 13.88B | ||
| +1.47% | +2.22% | -11.67% | -0.29% | 11.58B | ||
| -1.21% | +12.16% | +190.36% | +574.53% | 10.92B | ||
| +5.04% | -1.19% | -52.61% | -34.52% | 9.54B | ||
| +0.21% | +2.03% | +5.62% | +36.50% | 9.05B | ||
| -1.14% | +5.11% | -8.65% | +30.60% | 8.24B | ||
| -1.84% | -5.82% | -0.74% | +13.54% | 7.51B | ||
| -0.26% | -2.20% | -5.38% | +1.20% | 6.88B | ||
| +0.95% | -2.27% | -4.86% | +11.84% | 6.68B | ||
| -7.81% | -7.47% | -45.84% | -25.90% | 5.87B | ||
| Average | -0.48% | +1.61% | +1.58% | +35.03% | ||
| Weighted average by Cap. | -0.14% | +0.39% | +8.73% | +27.27% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
4ee830de325987015babd41fb74adbe.nkQ2iZsJ6fyrqXzqnJEENFXoS9IWQmsC9xts2KIwvlk.7hBp78JRpI7h50iGyadLZhaic5chD1NOu0s5tshW53Stdk_b7ULbv8LqKQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 01:30:00 am | 1.83 | 74,098 | 1,715,788 |
| 01:29:58 am | 1.82 | 100 | 1,641,690 |
| 01:29:56 am | 1.825 | 100 | 1,641,590 |
| 01:29:56 am | 1.83 | 274 | 1,641,490 |
| 01:29:56 am | 1.83 | 109 | 1,641,216 |
| 01:29:54 am | 1.825 | 100 | 1,641,107 |
| 01:29:53 am | 1.83 | 100 | 1,641,007 |
| 01:29:53 am | 1.83 | 174 | 1,640,907 |
| 01:29:53 am | 1.83 | 500 | 1,640,733 |
| 01:29:52 am | 1.82 | 500 | 1,640,233 |
Monthly variations
Annual change
| 2024 | -87.57% | ||
| 2023 | -60.16% | ||
| 2022 | +104.48% |
- Stock Market
- Equities
- AMLX Stock
- Quotes Amylyx Pharmaceuticals, Inc.
